Electromyography Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The electromyography devices market is anticipated to record a CAGR of nearly 10.1% during the forecast period. The increasing prevalence of neuromuscular disorders, such as motor neuron diseases, myasthenia gravis, myopathy, Parkinson's disease, peripheral neuropathy, and amyotrophic lateral sclerosis, and the surge in minimally invasive surgeries are expected to drive the market growth. As per the Global Institute for Health Metrics and Evaluation, in 2017, motor neuron diseases claimed more than 237,053 lives across the world. In addition, according to the Parkinson's Disease Foundation, more than 10.0 million individuals are currently suffering from Parkinson’s disease across the world. The increasing prevalence of this disease is anticipated to propel the market growth over the forecast period.

Technological advancements in EMG systems and the growing demand for portable EMG devices to curb the rising hospital and healthcare-associated costs are the key drivers that are likely to fuel the market growth. For instance, advancements in technologies, such as the RS-EMGx EMG System, which enables 4 channels of EMG recordings simultaneously from a single subject, are likely to govern the market.

Key Market Trends

The Portable EMG Devices Segment Dominates the Market

• By product mobility, the portable EMG devices segment is gaining traction, globally, as portable EMG devices offer benefits, such as extended care and remote monitoring from the doctor’s clinic at the patient’s home in case of management of chronic diseases. These devices are also used in ambulatory services and other paramedic settings where the electrical activity of the brain has to be measured, in order to understand the condition of the patient. Conditions, such as heart diseases and muscular disorders, are managed at economic rates, to reduce the number of visits to the doctor or hospitals. Such factors may support the segment's growth during the forecast period.
• Increasing awareness about the prevention of diseases and the available treatment options leading to early diagnosis, as well as increasing healthcare expenditure, are the factors anticipated to drive this segment’s growth over the forecast period.
• Moreover, a major factor contributing to the growth is the increasing focus of manufacturers on technological advancements, such as portability, lightweight, and simultaneous raw data acquisition, which may further propel the growth of the segment.

North America Represents the Largest Market and Asia-Pacific is Expected to Register Fastest Growth

Currently, North America dominates the market for electromyography devices , and it is expected to continue its stronghold for a few more years, due to high awareness, accompanied by high disease prevalence. Favorable government regulations and initiatives pertaining to the development of healthcare infrastructure also support the large share of this region.

Favorable reimbursement policies in the US have surged the usage of these systems for the diagnosis of neuromuscular disorders. The presence of government organizations, such as the National Institute of Neurological Disorders and Stroke (NINDS), that provide funding for R&D activities pertaining to the treatment of brain nervous disorders, contributed to the dominance of the regional market.

Competitive Landscape

The major players include companies, such as ADInstruments, A-M Systems, LLC, Ambu AS, Biometrics Ltd, Cometa Srl, Delsys Incorporated, Dexur, iWorx, Natus Medical Incorporated, and Neurosoft.

The major companies are undertaking various organic and inorganic strategies, such as new product developments, collaborations, acquisitions, mergers, and regional expansions, for serving the unmet needs of their customers. Many players are supporting their consumers via various strategies, such as training centers and arranging seminars, to make patients understand the main EMG capabilities, thereby, increasing their market penetration. For instance, Natus Medical Incorporated initiated the Patient Assistance Programs for creating awareness about routine EMG, nerve conduction studies, and advanced and quantitative methods of analysis.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support